Regular Use of Low-Dose Aspirin May Lower Risk of Women’s Breast Cancer, Study Reports

Regular Use of Low-Dose Aspirin May Lower Risk of Women’s Breast Cancer, Study Reports
Regular use of low-dose baby aspirin reduces the risk of women's breast cancer, according to the first research to reach such a conclusion. Aspirin is already known to reduce the risk of people having heart disease, colon disease and other conditions. The research involved a subset of patients in the huge California Teacher’s Study. Titled “Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study,” it was published online in Breast Cancer Research. Women who took 81 mg of aspirin at least three times a week were at 16 percent lower risk of developing breast cancer, according to Dr. Leslie Barnstein' research team at City of Hope, a renowned cancer center in Duarte, California. Another important finding was that regular doses of aspirin reduced the risk of a woman developing the most common breast cancer subtype, HER2 negative breast cancer, by 20 percent. "We already knew that aspirin is a weak aromatase inhibitor and we treat women with breast cancer with stronger aromatase inhibitors since they reduce the amount of estrogen postmenopausal women have circulating in their blood," Bernstein said in a press release. "We thought that if aspirin can inhibit aromatase, it ought to reduce the likelihood that breast cancer would develop, and it could also be an
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.